Joseph E. Payne

462 total citations
18 papers, 339 citations indexed

About

Joseph E. Payne is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Joseph E. Payne has authored 18 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Physiology and 4 papers in Cancer Research. Recurrent topics in Joseph E. Payne's work include Pharmacological Receptor Mechanisms and Effects (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Pain Mechanisms and Treatments (3 papers). Joseph E. Payne is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Pain Mechanisms and Treatments (3 papers). Joseph E. Payne collaborates with scholars based in United States, Sweden and Canada. Joseph E. Payne's co-authors include Christian A. Hassig, Thomas G. Back, Vikram Cariapa, Marciano Sablad, Kent T. Symons, Stewart A. Noble, Andrew K. Shiau, Nicholas D. Smith, Tadimeti S. Rao and Céline Bonnefous and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Joseph E. Payne

18 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph E. Payne United States 12 147 121 50 27 25 18 339
Maki Hirao Japan 7 205 1.4× 94 0.8× 26 0.5× 39 1.4× 11 0.4× 20 412
Birgitte W. Lund United States 12 170 1.2× 57 0.5× 37 0.7× 23 0.9× 19 0.8× 17 435
Abida Arshad Pakistan 8 200 1.4× 35 0.3× 40 0.8× 58 2.1× 15 0.6× 25 434
Deborah H. Slee United States 13 281 1.9× 162 1.3× 34 0.7× 35 1.3× 4 0.2× 18 554
Piyusha P. Pagare United States 11 165 1.1× 76 0.6× 69 1.4× 15 0.6× 64 2.6× 34 380
Róbert Alföldi Hungary 11 205 1.4× 50 0.4× 48 1.0× 48 1.8× 7 0.3× 15 364
Jenna Hutton United States 6 373 2.5× 63 0.5× 14 0.3× 17 0.6× 13 0.5× 6 492
Amanda Cobos‐Correa Switzerland 6 192 1.3× 43 0.4× 27 0.5× 34 1.3× 9 0.4× 9 385
Cheryl M. Ethen United States 10 376 2.6× 81 0.7× 16 0.3× 20 0.7× 9 0.4× 16 506
C W Slife United States 13 284 1.9× 154 1.3× 89 1.8× 21 0.8× 12 0.5× 17 492

Countries citing papers authored by Joseph E. Payne

Since Specialization
Citations

This map shows the geographic impact of Joseph E. Payne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Payne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Payne more than expected).

Fields of papers citing papers by Joseph E. Payne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph E. Payne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Payne. The network helps show where Joseph E. Payne may publish in the future.

Co-authorship network of co-authors of Joseph E. Payne

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. Payne. A scholar is included among the top collaborators of Joseph E. Payne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. Payne. Joseph E. Payne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kraehenbuehl, Rolf, Colin Capner, Gilda Padalino, et al.. (2023). Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica. Pharmaceutics. 15(7). 1869–1869. 2 indexed citations
2.
Cookson, Alan, Joseph E. Payne, Colin Capner, et al.. (2022). Flukicidal effects of abietane diterpenoid derived analogues against the food borne pathogen Fasciola hepatica.. Veterinary Parasitology. 309. 109766–109766. 3 indexed citations
3.
Tanis, Steven P., Rajesh Mukthavaram, Scott Roberts, et al.. (2020). Property-Driven Design and Development of Lipids for Efficient Delivery of siRNA. Journal of Medicinal Chemistry. 63(21). 12992–13012. 27 indexed citations
4.
Yaghi, Nasser K., Jun Wei, Yuuri Hashimoto, et al.. (2016). Immune modulatory nanoparticle therapeutics for intracerebral glioma. Neuro-Oncology. 19(3). now198–now198. 33 indexed citations
5.
Yaghi, Nasser K., Jun Wei, Ling‐Yuan Kong, et al.. (2015). Abstract 4291: An optimized therapeutic nanoparticle delivery platform of miRNA in preclinical murine models of malignancy. Cancer Research. 75(15_Supplement). 4291–4291. 1 indexed citations
6.
Symons, Kent T., Mark E. Massari, John V. Anzola, et al.. (2010). Pharmacological Characterization of KLYP961, a Dual Inhibitor of Inducible and Neuronal Nitric-Oxide Synthases. Journal of Pharmacology and Experimental Therapeutics. 336(2). 468–478. 12 indexed citations
7.
8.
Symons, Kent T., Mark E. Massari, Jeffrey Roppe, et al.. (2009). KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization. Molecular Pharmacology. 76(1). 153–162. 11 indexed citations
9.
10.
Payne, Joseph E., Céline Bonnefous, Christian A. Hassig, et al.. (2008). Identification of KD5170: A novel mercaptoketone-based histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(23). 6093–6096. 21 indexed citations
11.
Feng, Rentian, Huihui Ma, Christian A. Hassig, et al.. (2008). KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling. Molecular Cancer Therapeutics. 7(6). 1494–1505. 44 indexed citations
12.
Feng, Rentian, Jeffrey H. Hager, Christian A. Hassig, et al.. (2006). A Novel, Mercaptoketone-Based HDAC Inhibitor, KD5170 Exerts Marked Inhibition of Osteoclast Formation and Anti-Myeloma Activity In Vitro.. Blood. 108(11). 3477–3477. 3 indexed citations
13.
Poon, Steve F., Nicholas Stock, Joseph E. Payne, et al.. (2005). Novel approach to pro-drugs of lactones: water soluble imidate and ortho-ester derivatives of a furanone-based COX-2 selective inhibitor. Bioorganic & Medicinal Chemistry Letters. 15(9). 2259–2263. 7 indexed citations
14.
Smith, Nicholas D., Thomas S. Reger, Joseph E. Payne, et al.. (2005). Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia. Bioorganic & Medicinal Chemistry Letters. 15(13). 3197–3200. 3 indexed citations
15.
Back, Thomas G., et al.. (2001). Synthesis of (±)-Bakkenolide-A and Its C-7, C-10, and C-7,10 Epimers by Means of an Intramolecular Diels−Alder Reaction. The Journal of Organic Chemistry. 66(12). 4361–4368. 15 indexed citations
16.
Payne, Joseph E., Madhavan Nair, Julian L. Ambrus, & K. C. Chadha. (2000). Mild hyperthermia modulates biological activities of interferons. International Journal of Hyperthermia. 16(6). 492–507. 12 indexed citations
17.
Payne, Joseph E. & Vikram Cariapa. (2000). A fixture repeatability and reproducibility measure to predict the quality of machined parts. International Journal of Production Research. 38(18). 4763–4781. 21 indexed citations
18.
Back, Thomas G. & Joseph E. Payne. (1999). A Concise Total Synthesis of (±)-Bakkenolide A by Means of an Intramolecular Diels−Alder Reaction. Organic Letters. 1(4). 663–666. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maki Hirao Breakdown of academic impact, for papers by Birgitte W. Lund Breakdown of academic impact, for papers by Abida Arshad Breakdown of academic impact, for papers by Deborah H. Slee Breakdown of academic impact, for papers by Piyusha P. Pagare Breakdown of academic impact, for papers by Róbert Alföldi Breakdown of academic impact, for papers by Jenna Hutton Breakdown of academic impact, for papers by Amanda Cobos‐Correa Breakdown of academic impact, for papers by Cheryl M. Ethen Breakdown of academic impact, for papers by C W Slife
Rankless by CCL
2026